Finally, ELF5 mRNA expression in ovarian cancer [62] and ELF5 mRNA and protein in renal cell carcinoma [63] is reduced compared to corresponding normal tissue, and re-expression of ELF5 in cell line models of these cancers inhibits cell proliferation and survival [62,63]. This evidence concerns the gene ELF5 and ovarian cancer.